Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Sonde Health is a digital medicine company.
Imaginostics is creating the next generation of precision medicine diagnostic and prognostic tools.
Bolden Therapeutics is a biotechnology company developing first-in-class therapeutics to treat central nervous system diseases.
VivoSense is an advancing clinical research with wearable sensor solutions.
Biotechnology company developing pharmaceutical therapies for nerve regeneration in the central nervous system.
Piccolo Medical is a medical device company.
Olera is a health and wellness services provider that connects caregivers to service providers in the eldercare industry.
Akava Therapeutics is a small molecule therapeutics that inhibits protein aggregation, enzymes, and cancer for neurodegenerative diseases.
EIP Pharma is a clinical stage therapeutics company developing drugs to treat neurodegenerative diseases.
Rendever is a research-based virtual reality platform that provides cognitive stimulation, socialization, and therapy for older adults.
Solarea Bio develops microbial therapeutics aimed to treat indications derived from chronic inflammation to aid human health.
Software for Senior Care
RevBio was started with one goal in mind—to end medicine’s 50-year search for a biocompatible bone adhesive.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
ADvantage Therapeutics develops therapies to treat neurodegenerative conditions focusing on Alzheimer’s Disease.
BetterAge provides a personalized, web-based program to help individuals improve health and well-being.
SeeInMe develops a digital health platform designed to enhance person-centered coordinated care for care recipients.
Lighthouse Pharma's strategy combines translational insights with considerable clinical experience to understand and treat dementia.
Calder Biosciences is a groundbreaking biotechnology and molecular engineering firm developing next generation subunit vaccines
Amissa powers evidence-based perimenopause care with AI-enabled clinical decision support.
Lumia builds wearable that tracks blood flow to help people understand their bodies, improve well-being, and make proactive health choices.
Constantiam Biosciences is the resource for functional evidence in clinical genetics.
Amptify is an ecosystem of hearing health built to improve the provider and patient experience through comprehensive tech-enhanced care.
Evon Medics, LLC is focused on developing and delivering breakthrough therapeutics and devices to address brain-related conditions.
National Institute on Aging has invested in 65 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Institute on Aging's top investment sectors include Health Care, Biotechnology, Medical, Wellness, Therapeutics. The firm invests across 35 different industry categories.
Among tracked funding rounds, Lighthouse Pharma received $49.2M in a Grant round. National Institute on Aging's total known invested capital is $400.3M.
National Institute on Aging's average investment size is $7.4M across its portfolio of 65 companies.
Recent National Institute on Aging portfolio additions include Sonde Health, Imaginostics, Bolden Therapeutics, VivoSense, Novoron Bioscience. These companies were founded in 2020 or later.